Back
Altisource Portfolio Solutions SA Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Sell
6
ASPS
Altisource Portfolio Solutions SA
Last Price:
$6.62
Seasonality Move:
-5.17%
Buy
74
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.99
Seasonality Move:
4.89%
Sell
6
Altisource Portfolio Solutions SA (ASPS)
is a Sell
Is Altisource Portfolio Solutions SA a Buy, Sell or Hold?
-
The current Altisource Portfolio Solutions SA [ASPS] share price is $6.27. The Score for ASPS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
ASPS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
74
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $42.48. The Score for RIGL is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASPS Stock Price Chart
What is Altisource Portfolio Solutions SA's stock price today?
-
The Altisource Portfolio Solutions SA share price today is $6.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASPS is experiencing selling pressure, which indicates risk of future bearish movement.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $42.48The current trend is moderately bearish and RIGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 24.4 | Sell |
| Chaikin Money Flow: | -10114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.57 - 9.79) | Sell |
| Bollinger Bands (100): | (9.04 - 12.04) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 50.38 | Buy |
| Chaikin Money Flow: | 422611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.02 - 48.22) | Sell |
| Bollinger Bands (100): | (27.75 - 42.79) | Buy |
ASPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.39 | Sell |
| 20-day SMA: | 8.44 | Sell |
| 50-day SMA: | 9.92 | Sell |
| 200-day SMA: | 9.23 | Sell |
| 8-day EMA: | 7.18 | Sell |
| 20-day EMA: | 8.15 | Sell |
| 50-day EMA: | 9.31 | Sell |
| 200-day EMA: | 9.85 | Sell |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.57 | Sell |
| 20-day SMA: | 45.44 | Sell |
| 50-day SMA: | 37.1 | Buy |
| 200-day SMA: | 27.25 | Buy |
| 8-day EMA: | 43.13 | Sell |
| 20-day EMA: | 43.2 | Sell |
| 50-day EMA: | 39.44 | Buy |
| 200-day EMA: | 29.81 | Buy |
Altisource Portfolio Solutions SA Earnings Growth & ASPS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Altisource Portfolio Solutions SA Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||